AGEN vs SABS: stock comparison and AI forecast
Agenus Inc (AGEN) and Sab Biotherapeutics, Inc. (SABS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AGEN Agenus Inc
- Price
- $6.67 +60.0% · 6M
- Market Cap
- $300M
- P/E Ratio
- 3.3x
- Size
- small-cap
- AI Forecast
SABS Sab Biotherapeutics, Inc.
- Price
- $3.30 -10.6% · 6M
- Market Cap
- $284M
- P/E Ratio
- 156.0x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- AGEN and SABS have similar market capitalizations ($300M and $284M).
- AGEN trades at 3.3 times trailing earnings, SABS at 156.0 times.
- Over the last six months AGEN returned +60.0% and SABS -10.6%.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AGEN | SABS |
|---|---|---|
| Market Cap | $300M | $284M |
| P/E Ratio | 3.30x | 156.00x |
| P/B Ratio | – | 1.32x |
| EPS | $2.02 | $0.02 |
| Book Value/Share | – | $2.36 |
| Revenue/Share | $2.95 | – |
| FCF/Share | $-2.19 | – |
Profitability & Margins
| Metric | AGEN | SABS |
|---|---|---|
| ROA | 53.3% | – |
| ROIC | -61.2% | -31.7% |
| Gross Margin | 99.4% | – |
| Operating Margin | 27.3% | 6571.2% |
| Net Margin | 69.3% | – |
| EBT Margin | 40.2% | 878.0% |
Financial Health
| Metric | AGEN | SABS |
|---|---|---|
| Current Ratio | 0.34x | 9.22x |
| D/E Ratio | – | 0.11x |
| Financial Leverage | – | 1.11x |
| Interest Coverage | 22.1x | -377.0x |
| Working Capital | -$153M | $96M |
Cash Flow
| Metric | AGEN | SABS |
|---|---|---|
| Operating Cash Flow | -$98M | -$54M |
| Free Cash Flow | -$98M | – |
| Capital Spending | $0.00M | – |
| FCF/Sales | -74.2% | – |
| CapEx/Sales | 0.0% | – |
Operational Efficiency
| Metric | AGEN | SABS |
|---|---|---|
| Asset Turnover | 0.77x | – |
| Receivables Turnover | 9.0x | – |
| Fixed Assets Turnover | 9.3x | – |
| Days Sales Outstanding | 40 days | – |
| Payables Period | 27637 days | – |
Income Statement
| Metric | AGEN | SABS |
|---|---|---|
| Total Revenue | $133M | – |
| Operating Income | $36M | -$72M |
| Net Income | $92M | – |
| R&D Expense | $58M | $49M |
| Cost of Goods Sold | $780K | – |
Dividend & Shareholder Information
| Metric | AGEN | SABS |
|---|---|---|
| Shares Outstanding | 45M | 91M |
AGEN vs SABS: stock comparison and AI forecast
Which is bigger, AGEN or SABS?
AGEN and SABS have similar market capitalizations ($300M and $284M).
Which is cheaper on earnings, AGEN or SABS?
AGEN trades at 3.3 times trailing earnings, SABS at 156.0 times.
Which stock performed better over the last six months, AGEN or SABS?
Over the last six months AGEN returned +60.0% and SABS -10.6%.
Which one does Intratio's AI model rank higher, AGEN or SABS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.